HHV8-associated multicentric Castleman disease with Kaposi sarcoma in an immunocompetent patient: a case report and review of the literature.

J HematopOct 24, 2026 (epub)

K Hoerschgen, W Zhang, A Rappolt et al.

✦ AI-curated · Sources linked

Case in brief

A 57-year-old man presented with five months of generalized lymphadenopathy, weakness, cough, fever, and weight loss. HIV, CMV, EBV, and tuberculosis tests were negative. Examination of a lymph node showed both Kaposi sarcoma and HHV8-associated multicentric Castleman disease. Sequencing of the two lesions found no driver mutations but identified shared nonsynonymous polymorphisms in eight genes. Despite initial treatment with rituximab and doxorubicin, he died from complications of his illness.

What made this case unusual

Both lesions were present in the same lymph node in an HIV-negative, immunocompetent patient, without mucocutaneous manifestations. The report also profiled the concurrent lesions separately by targeted sequencing.

Diagnostic / clinical pearl

In an HIV-negative patient with generalized lymphadenopathy and systemic symptoms, consider HHV8-associated multicentric Castleman disease even without mucocutaneous signs; lymph-node histology may reveal concurrent Kaposi sarcoma.

Source

Published in J Hematop. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Hematology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.